Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,433.55INR
10:11am GMT
Change (% chg)

Rs-4.90 (-0.20%)
Prev Close
Rs2,438.45
Open
Rs2,444.00
Day's High
Rs2,445.00
Day's Low
Rs2,414.15
Volume
9,187
Avg. Vol
11,717
52-wk High
Rs2,780.05
52-wk Low
Rs2,201.20

Chart for

About

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The... (more)

Overall

Beta: 0.17
Market Cap(Mil.): Rs204,553.50
Shares Outstanding(Mil.): 84.70
Dividend: 30.00
Yield (%): 1.24

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.64
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-India's Glaxosmithkline Pharmaceuticals Dec Qtr Profit Rises

* DEC QUARTER PROFIT 896.9 MILLION RUPEES VERSUS PROFIT 529.5 MILLION RUPEES YEAR AGO

02 Feb 2018

BRIEF-Glaxosmithkline Pharmaceuticals ‍appoints Puja Thakur as CFO​

* Says ‍appointed Puja Thakur as whole-time director and CFO​ Source text: http://bit.ly/2gDubM1 Further company coverage:

25 Oct 2017

BRIEF-India's Glaxosmithkline Pharmaceuticals Sept-qtr profit up 32 pct

* Sept quarter profit 1.30 billion rupees versus profit of 988.5 million rupees last year

25 Oct 2017

Earnings vs. Estimates